Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02130284 · ClinicalTrials.gov registry record · NA
In Clinic Evaluation of the PLGM Feature
A NA study of Type 1 Diabetes, sponsored by Medtronic Diabetes.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 8
- Study locations
NCT02130284: Completed NA study of Type 1 Diabetes, sponsored by Medtronic Diabetes.
NCT02130284 is a NA study of Type 1 Diabetes that has completed, run by Medtronic Diabetes. The registered enrollment target is 80 participants, below the 766-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (90% lower). The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02130284, a NA study of Type 1 Diabetes, has completed, sponsored by Medtronic Diabetes.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study is a multi-center, single arm and in-clinic study to evaluate the safety of the PLGM System and its algorithm with the Enlite 3 Sensor.
Primary Outcome
Evaluation of incidence of SAE during in-clinic procedures
Conditions Studied
Interventions
- DEVICE Predictive Low Glucose Management Feature in Insulin pump
Study Locations (8)
California
- AMCR Institute, Inc. - Escondido
- Stanford University Department of Pediatric Endocrinology - Stanford
- Diablo Clinical Research - Walnut Creek
Colorado
- Barbara Davis Center of Childhood Diabetes - Denver
Connecticut
- Yale University Diabetes Research Program - New Haven
Georgia
- Atlanta Diabetes Associates - Atlanta
Virginia
- University of Virgina - Charlottesville
Washington
- Rainier Clinical Research - Renton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2014-10 |
| Est. Completion | 2015-09 |
| Phase | NA |
What the finished NCT02130284 record still lists
NCT02130284 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 766-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Predictive Low Glucose Management Feature in Insulin pump is the first listed.
NCT02130284 lists 8 locations in 6 states (California, Colorado, Connecticut).
Frequently Asked Questions
What is clinical trial NCT02130284 about?
NCT02130284 is a clinical study titled "In Clinic Evaluation of the PLGM Feature". This study is a multi-center, single arm and in-clinic study to evaluate the safety of the PLGM System and its algorithm with the Enlite 3 Sensor.
What is the current status of trial NCT02130284?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2014-10. Estimated completion is 2015-09.
What conditions does trial NCT02130284 study?
This clinical trial studies the following conditions: Type 1 Diabetes.
What interventions are being tested in trial NCT02130284?
The interventions under investigation include: Predictive Low Glucose Management Feature in Insulin pump (DEVICE).
Who is sponsoring clinical trial NCT02130284?
This trial is sponsored by Medtronic Diabetes, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02130284 being conducted?
This trial has 8 study locations across California, Colorado, Connecticut, Georgia, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02130284's enrollment target sits among peer trials
80 63rd of 198 higher than 133 of 198 other Type 1 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 1 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
REAL-Fam Feasibility Study for Youth Diabetes Management
RECRUITING · NA
-
AIDANET Pediatrics
RECRUITING · NA
-
A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery
RECRUITING · NA
-
EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia